Top compounds associated with response to LCE6A


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0024 0.9
mRNA prima-1 CTRPv2 pan-cancer AAC 0.002 0.9
mRNA BRD-K17060750 CTRPv2 pan-cancer AAC -0.0024 0.9
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.0021 0.9
mRNA Vorinostat GDSC1000 pan-cancer AAC 0.002 0.9
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0022 1
mRNA BMS-754807 CTRPv2 pan-cancer AAC 0.0021 1
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC -0.0019 1
mRNA PI-103 CTRPv2 pan-cancer AAC 0.0021 1
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.002 1
Download CSV